Company profile for Purple Biotech

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Purple Biotech Ltd. is a clinical-stage company focusing on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, to create successful long-lasting treatments for people with cancer. Our oncology pipeline includes NT219 and CM24.. The Company plans to advance CM24 as a combination therapy with anti-PD-1 checkpoint inhibitors in selected cancer indications in a phase 1 study followed by a pha...
Purple Biotech Ltd. is a clinical-stage company focusing on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, to create successful long-lasting treatments for people with cancer. Our oncology pipeline includes NT219 and CM24.. The Company plans to advance CM24 as a combination therapy with anti-PD-1 checkpoint inhibitors in selected cancer indications in a phase 1 study followed by a phase 2 for the treatment of non-small cell lung cancer and pancreatic cancer.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Israel
Address
Address
4 Oppenheimer St. Science Park, Rehovot
Telephone
Telephone
+ 972-3-9333121
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.clinicaltrialsarena.com/news/purple-biotech-begins-subject-dosing-in-pancreatic-cancer-therapy-trial/

CLINICAL TRIALS ARENA
15 Feb 2023
Purple snags Immunorizon's tri-specific antibodies in small M&A
Purple snags Immunorizon's tri-specific antibodies in small M&A

02 Feb 2023

// Annalee Armstrong FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/purple-biotech-paint-immunorizons-tri-specific-antibodies-100m-acquisition

Annalee Armstrong FIERCE BIOTECH
02 Feb 2023
Purple Biotech Appoints Lior Fhima as CFO
Purple Biotech Appoints Lior Fhima as CFO

02 Nov 2022

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2022/11/02/2546389/0/en/Purple-Biotech-Appoints-Lior-Fhima-as-Chief-Financial-Officer.html

GLOBENEWSWIRE
02 Nov 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty